PolyPid Ltd. (PYPD)
PYPD trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PYPD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Israel |
| IPO year | 2020 |
| SEC CIK | 0001611842 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | Israel |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Therefore, these factors raise a substantial doubt about the Company's ability to continue as a going concern." | 20-F 2026-02-25 |
| Cash and burn | $6.4M cash; operating cash flow -$7.0M a quarter. | Report 2025-12-31 |
| Shares outstanding | 18,204,002 (2025-12-31); 10,190,904 a year earlier; 19,851,833 three years earlier. 3y figure adjusted for split (1-for-30 overall); the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the market | Latest 2025-11-26 |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Kost Forer Gabbay & Kasierer, Haifa, Israel | PCAOB Form AP 2026-03-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | Not filed | -$34.2M | -$27.9M | $6.4M | $988K | Needs four quarters | 20-F 2026-02-25 |
| FY 2024 2024-12-31 | Not filed | -$29.0M | -$22.0M | $15.6M | $7.4M | Needs four quarters | 20-F 2026-02-25 |
| FY 2023 2023-12-31 | Not filed | -$23.9M | -$17.2M | $5.3M | $10.4M | Needs four quarters | 20-F 2026-02-25 |
| FY 2022 2022-12-31 | Not filed | -$39.6M | -$34.3M | $8.6M | $11.6M | Needs four quarters | 20-F 2025-02-26 |
| FY 2021 2021-12-31 | Not filed | -$42.6M | -$32.4M | $9.8M | No debt tags | Needs four quarters | 20-F 2024-03-06 |
| FY 2020 2020-12-31 | Not filed | -$36.9M | -$21.6M | $4.3M | No debt tags | Needs four quarters | 20-F 2023-03-31 |
| FY 2019 2019-12-31 | Not filed | -$6.9M | -$17.4M | $3.9M | No debt tags | Needs four quarters | 20-F 2022-02-28 |
| FY 2018 2018-12-31 | Not filed | $5.9M | -$16.7M | $7.8M | No debt tags | Needs four quarters | 20-F 2021-03-05 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-11-26 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-02-25 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-11-12 |
Source: SEC EDGAR submissions feed, 256 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.0% |
| 1 month | +28.3% |
| 3 months | +31.0% |
| Year to date | +44.2% |
| 1 year | +74.9% |
| From 52-week high | -5.2% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LUNG | Pulmonx Corporation | $2.80 | -2.10% | $121.9M |
| STIM | Neuronetics Inc. | $1.25 | -10.07% | $120.6M |
| APYX | Apyx Medical Corporation | $2.65 | -5.69% | $111.6M |
| SKYA | SkyAI Inc. | $2.11 | -9.05% | $107.3M |
| SKIN | SkinHealth Systems Inc. | $15.05 | -7.73% | $98.5M |
| KRMD | KORU Medical Systems Inc. Common Stock (DE) | $3.69 | -0.27% | $160.1M |
| ANIK | Anika Therapeutics Inc. | $12.92 | -3.58% | $173.1M |
| NYXH | Nyxoah SA | $0.8937 | -0.64% | $89.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier